Health Condition 1: null- Stable COPD patients
Conditions
Interventions
Intervention1: N-acetylcystiene and twenty minutes daily walk for ten weeks in addition to standard treatment: Tablet.600 mg N-acetylcytiene(effervecent) o.d. dissolved in water in combined with 20 mi
Sponsors
Dr Vijay Tukaram Salve
Dr Jitesh S Atram
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed as stable COPD on basis of FEV1 according to (GOLD guidelines 2010) of age 40yrs to 70 yrs
Exclusion criteria
Exclusion criteria: Patient in acute exacerbation in last 6weeks, patients with severe ischemic heart disease recent history of MI, stroke, severe hypertension (systolic >180 & diastolic >110),pulse >120, Patients who are unable to walk the predicted distance for their age in six minuteâ??s walk test, pregnant patients,elderly patients above 70 years.If in between the study patient present with acute exacerbation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There was statistically significant improvement in SGRQ-C score and quality of life in the study group P value 0.0001 while improvement in SGRQ-C score and quality of life in control group was not statistically significant.P value 0.118.Overall there was statistically significant improvement in SGRQ-C score and quality of life.P value 0.03 in the study group.Timepoint: Quality of life was assessed with Saint Geoerge Respiratory Questionaire-C(SGRQ-C) at the begining of the study and at the end of ten weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Same as primary outcome.Timepoint: There was improvement in the quality of life at the end of ten weeks in study group. | — |
Countries
India
Contacts
Public ContactVijay Tukaram Salve
Indira Gandhi Government Medical College
Outcome results
None listed